Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Multiple Sclerosis; Sclerosis | Phase 2 | ClinicalTrials |
| Autism Spectrum Disorder; Autistic Disorder | Phase 2 | ClinicalTrials |
| Autism Spectrum Disorder; Autistic Disorder | Phase 1 | ClinicalTrials |
| Psoriasis | Phase 2 | ClinicalTrials |
| Multiple Sclerosis; Sclerosis | Phase 2 | ClinicalTrials |
| Crohn Disease | Phase 1 | ClinicalTrials |
| Autism Spectrum Disorder; Autistic Disorder; Child Development Disorders, Pervasive | Phase 2 | ClinicalTrials |
| Colitis; Colitis, Ulcerative; Ulcer | Phase 2 | ClinicalTrials |
| Psoriasis | Phase 1 | ClinicalTrials |
CONTENTS